Another tough decision for Bayer as it plans to slash dividend by 95% to reduce debt kdunleavy Tue, 02/20/2024 – 10:18 More: Another tough decision for Bayer as it plans to slash dividend by 95% to reduce debt Source: fierce
read moreThe new programme will engage with children and young people under the age of 18 years More: New initiative to improve patient retention in paediatric clinical trials Source: News
read moreThe nanogels, in combination with rolipram, contributed to the recovery of injured tissue More: Researchers develop nanogel to deliver anti-inflammatory drugs for spinal cord injury Source: News
read moreThe study aims to improve the representation of ethnic diversity within Parkinson’s research More: Predict-PD study to identify those at high risk of PD before symptoms appear Source: News
read moreParticipants who received COMPASS showed a clinically significant improvement after 12 weeks More: Digital CBT reduced distress in patients with long-term physical health conditions Source: News
read moreFDA approves Iovance’s Amtagvi as first T-cell therapy for a solid tumor aliu Fri, 02/16/2024 – 22:04 More: FDA approves Iovance’s Amtagvi as first T-cell therapy for a solid tumor Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals